BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22076477)

  • 21. Review and evaluation of performance measures for survival prediction models in external validation settings.
    Rahman MS; Ambler G; Choodari-Oskooei B; Omar RZ
    BMC Med Res Methodol; 2017 Apr; 17(1):60. PubMed ID: 28420338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The development and validation of risk prediction model for lung cancer: a systematic review].
    Lyu ZY; Tan FW; Lin CQ; Li J; Wang YL; Chen HD; Ren JS; Shi JF; Feng XS; Wei LP; Li X; Wen Y; Chen WQ; Dai M; Li N; He J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Apr; 54(4):430-437. PubMed ID: 32268653
    [No Abstract]   [Full Text] [Related]  

  • 23. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
    Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
    BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation of multivariable prediction models: a systematic review of methodological conduct and reporting.
    Collins GS; de Groot JA; Dutton S; Omar O; Shanyinde M; Tajar A; Voysey M; Wharton R; Yu LM; Moons KG; Altman DG
    BMC Med Res Methodol; 2014 Mar; 14():40. PubMed ID: 24645774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-induced anaemia during adjuvant treatment for breast cancer: development of a prediction model.
    Dranitsaris G; Clemons M; Verma S; Lau C; Vincent M
    Lancet Oncol; 2005 Nov; 6(11):856-63. PubMed ID: 16257793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrimination and calibration of mortality risk prediction models in interventional cardiology.
    Matheny ME; Ohno-Machado L; Resnic FS
    J Biomed Inform; 2005 Oct; 38(5):367-75. PubMed ID: 16198996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models.
    Austin PC; Steyerberg EW
    Stat Methods Med Res; 2017 Apr; 26(2):796-808. PubMed ID: 25411322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands.
    van Steenbeek CD; van Maaren MC; Siesling S; Witteveen A; Verbeek XAAM; Koffijberg H
    BMC Med Res Methodol; 2019 Jun; 19(1):117. PubMed ID: 31176362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gail model risk factors: impact of adding an extended family history for breast cancer.
    Crispo A; D'Aiuto G; De Marco M; Rinaldo M; Grimaldi M; Capasso I; Amore A; Bosetti C; La Vecchia C; Montella M
    Breast J; 2008; 14(3):221-7. PubMed ID: 18373641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the success of IVF: external validation of the van Loendersloot's model.
    Sarais V; Reschini M; Busnelli A; Biancardi R; Paffoni A; Somigliana E
    Hum Reprod; 2016 Jun; 31(6):1245-52. PubMed ID: 27076503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External model validation of binary clinical risk prediction models in cardiovascular and thoracic surgery.
    Hickey GL; Blackstone EH
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):351-5. PubMed ID: 27215928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk models to predict hypertension: a systematic review.
    Echouffo-Tcheugui JB; Batty GD; Kivimäki M; Kengne AP
    PLoS One; 2013; 8(7):e67370. PubMed ID: 23861760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.
    Tice JA; Miike R; Adduci K; Petrakis NL; King E; Wrensch MR
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):324-8. PubMed ID: 15734953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk.
    Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Hankinson SE; Marcantonio ER; Ngo LH
    Breast Cancer Res Treat; 2016 Dec; 160(3):547-562. PubMed ID: 27770283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.
    James MT; Pannu N; Hemmelgarn BR; Austin PC; Tan Z; McArthur E; Manns BJ; Tonelli M; Wald R; Quinn RR; Ravani P; Garg AX
    JAMA; 2017 Nov; 318(18):1787-1797. PubMed ID: 29136443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique.
    Takada M; Sugimoto M; Ohno S; Kuroi K; Sato N; Bando H; Masuda N; Iwata H; Kondo M; Sasano H; Chow LW; Inamoto T; Naito Y; Tomita M; Toi M
    Breast Cancer Res Treat; 2012 Jul; 134(2):661-70. PubMed ID: 22689089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NanoString-based breast cancer risk prediction for women with sclerosing adenosis.
    Winham SJ; Mehner C; Heinzen EP; Broderick BT; Stallings-Mann M; Nassar A; Vierkant RA; Hoskin TL; Frank RD; Wang C; Denison LA; Vachon CM; Frost MH; Hartmann LC; Aubrey Thompson E; Sherman ME; Visscher DW; Degnim AC; Radisky DC
    Breast Cancer Res Treat; 2017 Nov; 166(2):641-650. PubMed ID: 28798985
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.